Products

What will AGI do for Bendamustine?

This classification denotes a nitrogen mustard compound with the molecular formula C16H21Cl2N3O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 9266D9P3PQ, chemically known as 2-benzimidazolinebutryric acid, 1-methyl-5-bis(2-chloroethyl)amino-, hydrochloride but more generally known as bendamustine, which bears US NIH Compound Identifier 65628. Bendamustine most often comes in base and hydrochloride forms. European Medicines Agency schedules Bendamustine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05707MIG. The term BENDAMUSTINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 37, No. 6, 1983, List 23). World Health Organization schedules bendamustine in its Anatomical Therapeutic Chemical (ATC) Classification. BENDAMUSTINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations, for tariff and trade purposes, schedule bendamustine under HS 29339990 and SITC 51577. As of Q4 2014, BENDAMUSTINE remains US FDA's Preferred Term for this commodity. Bendamustine bears US NLM identifiers UMLS ID C0525079 and NCI Concept Code C73261. SMILES: CLCCN(C1CC2NC(N(C2CC1)C)CCCC(=O)O)CCCL.